Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: A pilot study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 16, 2016
- Accepted in final form November 22, 2016
- First Published December 21, 2016.
Article Versions
- Previous version (December 21, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Felix Kleefeld,
- Sophie Heller,
- Heiko Jessen, MD,
- Patrick Ingiliz, MD,
- Antje Kraft, PhD and
- Katrin Hahn, MD
- Felix Kleefeld,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sophie Heller,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Heiko Jessen, MD,
Gilead Sciences GmbH, Bioscientia-Institute f?r Medizinische Diagnostik GmbH, ViiV Healthcare GmbH
NONE
Gilead Sciences GmbH, ViiV Healthcare GmbH, Abbvie Deutschland GmbH & Co.KG, Bristol-Myers Squib GmbH & Co.KGaA
NONE
NONE
NONE
NONE
Bioscientia-Institute f?r Medizinische Diagnostik GmbH
Gilead Sciences GmbH, ViiV Healthcare GmbH, Abbvie Deutschland GmbH & Co.KG, Bristol-Myers Squib GmbH & Co.KGaA
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Patrick Ingiliz, MD,
1) Abbvie 2) Gilead 3) ViiV
NONE
1) Abbvie 2) Gilead 3) BMS 4) MSD 5)Janssen-Cilag
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Antje Kraft, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Katrin Hahn, MD
Katrin Hahn served as an advisor on a scientific advisory board (Ultragenyx-commercial entity).
NONE
Katrin Hahn, - has received honoraria for speaking engagements as well as travel honoraria from commercial entities such as AbbVie, Astellas, CSL Behring, Gilead, Pfizer, ViiV.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From Universitätsmedizin Charité (F.K., S.H., A.K., K.H.); Praxis Jessen2+Kollegen Berlin (H.J.); and Medizinisches Infektiologiezentrum Berlin (P.I.), Germany.
- Correspondence to Dr. Hahn: Katrin.hahn{at}charite.de
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Hepatitis C virus infection as a risk factor for Parkinson diseaseA nationwide cohort studyHsin-Hsi Tsai, Horng-Huei Liou, Chih-Hsin Muo et al.Neurology, December 23, 2015 -
Brief Communications
Hepatitis C virus infection and neurocognitive functionM. Soogoor, H. S. Lynn, S. M. Donfield et al.Neurology, October 23, 2006 -
Articles
Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamineM. Cherner, S. Letendre, R. K. Heaton et al.Neurology, April 07, 2005 -
Article
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected peopleDavid B. Clifford, Florin Vaida, Yu-Ting Kao et al.Neurology, December 10, 2014